key: cord-0892807-7pdn93qa
authors: Mossad, Sherif B.
title: SARS‐CoV‐2 vaccine effectiveness trumps immunogenicity in solid organ transplant recipients
date: 2021-07-16
journal: Am J Transplant
DOI: 10.1111/ajt.16744
sha: 95c5029f3c0967c0d7fe27688afa7248934693b5
doc_id: 892807
cord_uid: 7pdn93qa

On June 8th , Malinis et al, published their preliminary observations of the SARS-CoV-2 vaccine effectiveness in solid organ transplant recipients (SOTR) in the AJT (1). Their timely, real world results based on current practices are reassuring. Several studies have now shown 100% effectiveness of multiple SARS-CoV-2 vaccines in preventing hospitalization and death. As of May 17th , 2021, 860 of 123 million (0.0008%) who were fully vaccinated developed breakthrough infections that required hospitalization or were fatal.

To the Editor: 

Effectiveness of SARS-CoV-2 vaccination in fully-vaccinated solid organ transplant recipients

COVID-19 serologic testing: FAQs and caveats

Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers -eight

Statement on COVID-19 vaccination in solid organ transplant recipients

Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants